Skip to Content

Kintor Pharmaceutical Ltd Ordinary Shares 09939 Stock Quote

| Rating as of

XHKG: 09939

Market Closed

| Currency in HKD

  • Last Close 2.74
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Value
  • Day Range 2.69  –  2.77
  • Year Range 2.63  –  16.22
  • Market Cap 1.2261 Bil
  • Volume / Avg 293,000.0 /  4.1 Mil
  • Price / Sales
  • Price / Book 0.91
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis 09939

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics 09939

Company Profile 09939

Business Description

Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China focused on the proprietary R&D of drugs for cancers and other AR-related diseases. The company's drug candidate, Pruxelutamide, is a drug undergoing phase III clinical trials in China and phase III clinical trials in the United States for mCRPC as well as clinical trials for breast cancer. Its pipeline of seven drug candidates includes Pruxelutamide (GT0918), Pyrilutamide (KX-826), ALK-1 (GT90001), Detorsertib (GT0486), Hedgehog/SMO Inhibitor (GT1708F), PD-L1/TGF-ß (GT90008), and AR-PROTAC Compound (GT20029). It operates in a single segment focusing on the research and development of medical products.

No. 20 Songbei Road, Suzhou Industrial Park, Jiangsu
Suzhou, 215123, CHN
Industry Biotechnology
Employees 290

Competitors & Peers 09939

Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.

Kintor Pharmaceutical Ltd Ordinary Shares

XHKG: 09939

JW (Cayman) Therapeutics Co Ltd Ordinary Shares

XHKG: 02126

Alphamab Oncology Ordinary Shares

XHKG: 09966

3SBio Inc Shs Unitary 144A/Reg S

XHKG: 01530
+$0.06 (2.24%) +$0.02 (0.98%) −$0.45 (4.97%) −$0.15 (2.24%)
Market Cap
1.23 Bil851.88 Mil8.30 Bil15.97 Bil
Biotechnology Biotechnology Biotechnology Biotechnology

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Kintor Pharmaceutical Ltd Ordinary Shares Stock

No. 09939 does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

09939’s market cap is 1.23 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

09939’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

09939’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare 09939’s historical performance against its industry peers and the overall market.